DuPont addresses biofuels, biochemicals during Investor Day event

Biorefining Magazine
By Erin Voegele December 15, 2011

DuPont recently held its 2011 Investor Day event during which the company Chair and CEO Ellen Kullman and its senior leaders detailed the global growth strategy of DuPont and its business segments. Regarding its Industrial Biosciences segment, the presentation noted that long-term compound annual sales growth is expected to be 10 to 12 percent, with pretax operating income margins between 15 and 17 percent. The company said this growth will be driven by continued innovations and the commercialization of DuPont’s biofuels business, and that new products, productivity and cost synergies will contribute to the achievement of margin goals.

Read more